SCHEMBL5651640

SCHEMBL5651640

Cc1cc(N)cnc1OCc1ccc(F)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOB P27338 6/20 0.49
MGMT P16455 2/20 0.45
MPO P05164 1/20 0.43
LMNA P02545 2/20 0.42
MAPT P10636 2/20 0.42
POLB P06746 1/20 0.42
STAT3 P40763 1/20 0.42
HTT P42858 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
IDO1 P14902 2/20 0.41
AGXT P21549 2/20 0.41
MEN1 O00255 1/20 0.40
KMT2A Q03164 1/20 0.40
KDM5A P29375 1/20 0.39
KDM4C Q9H3R0 1/20 0.39
KDM5B Q9UGL1 1/20 0.39
CNR1 P21554 2/20 0.38
CNR2 P34972 2/20 0.38
ABHD6 Q9BV23 1/20 0.38
APP P05067 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5652395 0.88 PIN1 (0.45) MAOBMPOMAPTAGXTMEN1
SCHEMBL5649684 0.85 CYP17A1 (0.43) MAOBMPOLMNAMAPTPOLB
SCHEMBL5648620 0.84 L3MBTL1 (0.47) MAOBMGMTMPOLMNAMAPT
Hydrochloric Acid SCHEMBL15669833 0.82 MAOB (0.53) MAOBMGMTMPOLMNAMAPT
SCHEMBL15669834 0.81 FFAR1 (0.41) MAOBMGMTLMNAMAPTPOLB
SCHEMBL15351339 0.80 LMNA (0.39) MAOBMGMTMPOLMNAMAPT
SCHEMBL5650853 0.79 RAB9A (0.41) LMNAPOLBHTTSMN1; SMN2MEN1
SCHEMBL15351722 0.77 MAOB (0.56) MAOBMEN1KMT2AKDM5AKDM4C
SCHEMBL15350256 0.77 KDM5A (0.54) MAOBKDM5AKDM4CKDM5B
SCHEMBL21078951 0.76 MAOB (0.38) MAOBMGMTLMNAMAPTPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7235559-B1 Therapeutic quinazoline derivatives ASTRAZENECA AB (SE) 2007-06-26 US disclosed
EP-1218355-A1 THERAPEUTIC QUINAZOLINE DERIVATIVES AstraZeneca AB (SE) 2002-07-03 EP disclosed
WO-2001021597-A1 THERAPEUTIC QUINAZOLINE DERIVATIVES ASTRAZENECA AB (SE) 2001-03-29 WO disclosed